These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 10231167

  • 21. Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
    Jacobsen NW, Hansen CH, Nellemann C, Styrishave B, Halling-Sørensen B.
    Toxicol In Vitro; 2015 Oct; 29(7):1729-35. PubMed ID: 26162595
    [Abstract] [Full Text] [Related]

  • 22. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats.
    Zhou FC, McKinzie DL, Patel TD, Lumeng L, Li TK.
    Alcohol Clin Exp Res; 1998 Feb; 22(1):266-9. PubMed ID: 9514317
    [Abstract] [Full Text] [Related]

  • 23. [Differential features of SSRIs].
    Cervera S.
    Rev Med Univ Navarra; 1997 Feb; 41(4):245-57. PubMed ID: 10420965
    [Abstract] [Full Text] [Related]

  • 24. The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line.
    Hansen CH, Larsen LW, Sørensen AM, Halling-Sørensen B, Styrishave B.
    Toxicol In Vitro; 2017 Jun; 41():1-11. PubMed ID: 28179152
    [Abstract] [Full Text] [Related]

  • 25. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
    de Jong TR, Pattij T, Veening JG, Waldinger MD, Cools AR, Olivier B.
    Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
    Dunham KE, Venton BJ.
    J Neurochem; 2022 Sep; 162(5):404-416. PubMed ID: 35736504
    [Abstract] [Full Text] [Related]

  • 28. Are pharmacokinetic drug interactions with the SSRIs an issue?
    Brøsen K.
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():23-7. PubMed ID: 8732441
    [Abstract] [Full Text] [Related]

  • 29. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat.
    Mos J, Mollet I, Tolboom JT, Waldinger MD, Olivier B.
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):123-35. PubMed ID: 10082238
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of selective serotonin reuptake inhibitors.
    Hiemke C, Härtter S.
    Pharmacol Ther; 2000 Jan; 85(1):11-28. PubMed ID: 10674711
    [Abstract] [Full Text] [Related]

  • 31. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
    Edwards JG, Anderson I.
    Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
    [Abstract] [Full Text] [Related]

  • 32. Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
    Carrasco JL, Sandner C.
    Int J Clin Pract; 2005 Dec; 59(12):1428-34. PubMed ID: 16351675
    [Abstract] [Full Text] [Related]

  • 33. [The transfer of selective serotonin reuptake inhibitors to human milk].
    Nordeng H, Bergsholm YK, Bøhler E, Spigset O.
    Tidsskr Nor Laegeforen; 2001 Jan 20; 121(2):199-203. PubMed ID: 11475200
    [Abstract] [Full Text] [Related]

  • 34. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K, Kimura R, Sugimoto Y, Yamada J, Uchida S, Kato Y, Hashimoto H, Yamada S.
    Br J Pharmacol; 2005 Mar 20; 144(5):695-702. PubMed ID: 15678084
    [Abstract] [Full Text] [Related]

  • 35. Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
    Stahl SM.
    J Clin Psychiatry; 1998 Dec 20; 59(12):642-3. PubMed ID: 9921697
    [No Abstract] [Full Text] [Related]

  • 36. 5-HT2A and 5-HT2C/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats.
    Maurel S, De Vry J, De Beun R, Schreiber R.
    Pharmacol Biochem Behav; 1999 Jan 20; 62(1):89-96. PubMed ID: 9972850
    [Abstract] [Full Text] [Related]

  • 37. Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats.
    Ciccocioppo R, Panocka I, Polidori C, Dourish CT, Massi M.
    Psychopharmacology (Berl); 1997 Nov 20; 134(1):55-63. PubMed ID: 9399367
    [Abstract] [Full Text] [Related]

  • 38. [Selective serotonin reuptake inhibitors--current knowledge].
    Dudek D, Zieba A, Siwek M, Wróbel A.
    Psychiatr Pol; 2004 Nov 20; 38(3):507-24. PubMed ID: 15199659
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C, Hyttel J.
    Cell Mol Neurobiol; 1999 Aug 20; 19(4):467-89. PubMed ID: 10379421
    [Abstract] [Full Text] [Related]

  • 40. Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine.
    Luong TT, Powers CN, Reinhardt BJ, Weina PJ.
    Curr Res Pharmacol Drug Discov; 2022 Aug 20; 3():100112. PubMed ID: 35756846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.